Navigation Links
GENEWIZ To Launch Single-Cell RNA-Seq Services At AACR
Date:3/28/2017

SOUTH PLAINFIELD, N.J. and WASHINGTON, March 28, 2017 /PRNewswire/ -- (AACR17, Booth #3431) – Leading global genomics service provider, GENEWIZ, will launch single-cell sequencing during the American Association for Cancer Research (AACR) Annual Meeting at the Walter E. Washington Convention Center in Washington, D.C., April 1-5, 2017. Single-Cell RNA-Seq allows researchers to perform differential gene expression of thousands of cells at the individual level.

Highlights:

  • Experts on-hand at AACR to discuss expanded next generation sequencing service offerings for cancer researchers including single-cell sequencing with the 10x Genomics® Chromium™, and whole genome sequencing with the Illumina HiSeq™ X Ten and the PacBio® Sequel.
  • Show-only discounts on GENEWIZ's complete service offering including: next generation and Sanger sequencing, gene synthesis, and GLP-compliant services.
  • Poster presentation in conjunction with Celsee Diagnostics:
    "Enrichment and Mutation Detection of Circulating Tumor Cells from Blood Samples"
    Liquid Biopsies 1: Circulating Tumor Cells
    Monday, April 3 -- 8 a.m. to Noon
    Poster Section 30 / Poster Board 10
Continue Reading
 (PRNewsFoto/GENEWIZ)
(PRNewsFoto/GENEWIZ)...

"We are excited to introduce our new single-cell sequencing workflow at AACR as it will bring cancer researchers complete access to critical molecular information down to the cellular level," said Dr. Ginger Zhou, director of genomics and molecular genetics, GENEWIZ. "AACR brings together the best and the brightest in cancer research, making it an excellent opportunity for us to collaborate on new technologies and proprietery protocols that will help scientists advance their discoveries faster than ever before and ultimately transform cancer genomics."

About GENEWIZ
GENEWIZ is a global leader in genomics services that enable research scientists within pharmaceutical, biotechnology, agriculture, environmental and clean energy, academic, and government institutions to advance their discoveries. Customers rely on our unique and proprietary genomics technologies and services, backed by our specialized experts in DNA sequencing, gene synthesis, molecular biology, high throughput sequencing, bioinformatics, and GLP regulatory-compliant services.

Headquartered in South Plainfield, NJ, GENEWIZ is privately-held with a global network of laboratories in Boston, MA; Washington, D.C. Metro; Research Triangle Park, NC; San Diego, CA; Los Angeles, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, Suzhou, and Tianjin, China; Takeley, United Kingdom; and Tokyo, Japan.  For more information, visit www.genewiz.com, and connect with us on LinkedIn, Twitter, Facebook, YouTube, WeChat, and Weibo.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/genewiz-to-launch-single-cell-rna-seq-services-at-aacr-300430642.html


'/>"/>
SOURCE GENEWIZ
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. GENEWIZ Chosen For The Inc. 5000 List Of Fastest-Growing Private Companies For Third Year In A Row
2. Global Genomics Company, GENEWIZ, Receives Investment
3. Sigma-Aldrich Collaborates with GENEWIZ and Oxford Genetics to Speed Ordering Process for DNA Services
4. GENEWIZ Joins Inc. 5000 List of Fastest-growing Private Companies for Second Consecutive Year
5. GENEWIZ to Present at PEGS Europe Protein & Antibody Summit
6. Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz
7. Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz
8. Research and Markets Has Announced the Launch of Their Valero Energy Market Research Portal
9. DarioHealth Launches Insurance Coverage Option for U.S. Consumers
10. SeraCare Life Sciences announces launch of industrys first multiplexed Inherited Cancer reference material
11. Easy-to-Use Vertical Garden EcoQube Frame, for Growing Micro-Veggies Indoors Quickly and Affordably, Crushes Crowdfunding Goal Minutes After Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... At ... Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist ... has been selected for membership in ARCS Alumni Hall of Fame . ...
(Date:10/11/2017)... Wayne. NJ (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a ... rinse one eye at a time. So which eye do you rinse first if a ... you have Plum Duo Eye Wash with its unique dual eye piece. , ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
Breaking Biology Technology:
(Date:4/13/2017)... SANTA MONICA, Calif. , April 13, 2017 /PRNewswire/ ... New York will feature emerging and ... Innovation Summits. Both Innovation Summits will run alongside the ... variety of speaker sessions, panels and demonstrations focused on ... east coast,s largest advanced design and manufacturing event will ...
(Date:4/11/2017)... 2017 No two people are believed ... New York University Tandon School of Engineering and ... that partial similarities between prints are common enough ... phones and other electronic devices can be more ... lies in the fact that fingerprint-based authentication systems ...
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
Breaking Biology News(10 mins):